Skip to content

Biohaven BHVN Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$1.11B+95.7%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$484.7M+66.6%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$522.99M-43.9%
uniQure logo
uniQureQURE
$615.74M+41.4%
Roivant Sciences logo
Roivant SciencesROIV
$5.17B+3.3%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's total current assets?
Biohaven (BHVN) reported total current assets of $385.65M in Q1 2026.
How has Biohaven's total current assets changed year-over-year?
Biohaven's total current assets increased by 0.8% year-over-year, from $382.76M to $385.65M.
What is the long-term trend for Biohaven's total current assets?
Over 4 years (2021 to 2025), Biohaven's total current assets has grown at a 40.4% compound annual growth rate (CAGR), from $94.82M to $368.33M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.